These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
507 related articles for article (PubMed ID: 23644383)
1. cAMP/PKA signalling reinforces the LATS-YAP pathway to fully suppress YAP in response to actin cytoskeletal changes. Kim M; Kim M; Lee S; Kuninaka S; Saya H; Lee H; Lee S; Lim DS EMBO J; 2013 May; 32(11):1543-55. PubMed ID: 23644383 [TBL] [Abstract][Full Text] [Related]
2. Tumor suppressor LATS1 is a negative regulator of oncogene YAP. Hao Y; Chun A; Cheung K; Rashidi B; Yang X J Biol Chem; 2008 Feb; 283(9):5496-509. PubMed ID: 18158288 [TBL] [Abstract][Full Text] [Related]
3. The Hippo pathway is controlled by Angiotensin II signaling and its reactivation induces apoptosis in podocytes. Wennmann DO; Vollenbröker B; Eckart AK; Bonse J; Erdmann F; Wolters DA; Schenk LK; Schulze U; Kremerskothen J; Weide T; Pavenstädt H Cell Death Dis; 2014 Nov; 5(11):e1519. PubMed ID: 25393475 [TBL] [Abstract][Full Text] [Related]
4. The Hippo pathway regulator KIBRA promotes podocyte injury by inhibiting YAP signaling and disrupting actin cytoskeletal dynamics. Meliambro K; Wong JS; Ray J; Calizo RC; Towne S; Cole B; El Salem F; Gordon RE; Kaufman L; He JC; Azeloglu EU; Campbell KN J Biol Chem; 2017 Dec; 292(51):21137-21148. PubMed ID: 28982981 [TBL] [Abstract][Full Text] [Related]
5. A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis. Moroishi T; Park HW; Qin B; Chen Q; Meng Z; Plouffe SW; Taniguchi K; Yu FX; Karin M; Pan D; Guan KL Genes Dev; 2015 Jun; 29(12):1271-84. PubMed ID: 26109050 [TBL] [Abstract][Full Text] [Related]
6. Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway. Mo JS; Meng Z; Kim YC; Park HW; Hansen CG; Kim S; Lim DS; Guan KL Nat Cell Biol; 2015 Apr; 17(4):500-10. PubMed ID: 25751140 [TBL] [Abstract][Full Text] [Related]
7. Deubiquitinating Enzyme USP9X Suppresses Tumor Growth via LATS Kinase and Core Components of the Hippo Pathway. Toloczko A; Guo F; Yuen HF; Wen Q; Wood SA; Ong YS; Chan PY; Shaik AA; Gunaratne J; Dunne MJ; Hong W; Chan SW Cancer Res; 2017 Sep; 77(18):4921-4933. PubMed ID: 28720576 [TBL] [Abstract][Full Text] [Related]
8. The Hippo pathway member Nf2 is required for inner cell mass specification. Cockburn K; Biechele S; Garner J; Rossant J Curr Biol; 2013 Jul; 23(13):1195-201. PubMed ID: 23791728 [TBL] [Abstract][Full Text] [Related]
9. Protein kinase A activates the Hippo pathway to modulate cell proliferation and differentiation. Yu FX; Zhang Y; Park HW; Jewell JL; Chen Q; Deng Y; Pan D; Taylor SS; Lai ZC; Guan KL Genes Dev; 2013 Jun; 27(11):1223-32. PubMed ID: 23752589 [TBL] [Abstract][Full Text] [Related]
10. Arhgef7 promotes activation of the Hippo pathway core kinase Lats. Heidary Arash E; Song KM; Song S; Shiban A; Attisano L EMBO J; 2014 Dec; 33(24):2997-3011. PubMed ID: 25425573 [TBL] [Abstract][Full Text] [Related]
11. Angiomotins stimulate LATS kinase autophosphorylation and act as scaffolds that promote Hippo signaling. Mana-Capelli S; McCollum D J Biol Chem; 2018 Nov; 293(47):18230-18241. PubMed ID: 30266805 [TBL] [Abstract][Full Text] [Related]
12. Role of Angiomotin-like 2 mono-ubiquitination on YAP inhibition. Kim M; Kim M; Park SJ; Lee C; Lim DS EMBO Rep; 2016 Jan; 17(1):64-78. PubMed ID: 26598551 [TBL] [Abstract][Full Text] [Related]
13. Cyclic AMP-dependent protein kinase phosphorylates merlin at serine 518 independently of p21-activated kinase and promotes merlin-ezrin heterodimerization. Alfthan K; Heiska L; Grönholm M; Renkema GH; Carpén O J Biol Chem; 2004 Apr; 279(18):18559-66. PubMed ID: 14981079 [TBL] [Abstract][Full Text] [Related]
14. WWC1 and NF2 Prevent the Development of Intrahepatic Cholangiocarcinoma by Regulating YAP/TAZ Activity through LATS in Mice. Park J; Kim JS; Nahm JH; Kim SK; Lee DH; Lim DS Mol Cells; 2020 May; 43(5):491-499. PubMed ID: 32451369 [TBL] [Abstract][Full Text] [Related]
15. Arsenic-induced cutaneous hyperplastic lesions are associated with the dysregulation of Yap, a Hippo signaling-related protein. Li C; Srivastava RK; Elmets CA; Afaq F; Athar M Biochem Biophys Res Commun; 2013 Sep; 438(4):607-12. PubMed ID: 23942117 [TBL] [Abstract][Full Text] [Related]
16. Mst2 and Lats kinases regulate apoptotic function of Yes kinase-associated protein (YAP). Oka T; Mazack V; Sudol M J Biol Chem; 2008 Oct; 283(41):27534-27546. PubMed ID: 18640976 [TBL] [Abstract][Full Text] [Related]
17. YAP Mediates Hair Cell Regeneration in Balance Organs of Chickens, But LATS Kinases Suppress Its Activity in Mice. Rudolf MA; Andreeva A; Kozlowski MM; Kim CE; Moskowitz BA; Anaya-Rocha A; Kelley MW; Corwin JT J Neurosci; 2020 May; 40(20):3915-3932. PubMed ID: 32341094 [TBL] [Abstract][Full Text] [Related]
18. The characterisation of LATS2 kinase regulation in Hippo-YAP signalling. Hoa L; Kulaberoglu Y; Gundogdu R; Cook D; Mavis M; Gomez M; Gomez V; Hergovich A Cell Signal; 2016 May; 28(5):488-497. PubMed ID: 26898830 [TBL] [Abstract][Full Text] [Related]
19. Regulation of Hippo pathway by mitogenic growth factors via phosphoinositide 3-kinase and phosphoinositide-dependent kinase-1. Fan R; Kim NG; Gumbiner BM Proc Natl Acad Sci U S A; 2013 Feb; 110(7):2569-74. PubMed ID: 23359693 [TBL] [Abstract][Full Text] [Related]
20. Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility. Wang Z; Wu Y; Wang H; Zhang Y; Mei L; Fang X; Zhang X; Zhang F; Chen H; Liu Y; Jiang Y; Sun S; Zheng Y; Li N; Huang L Proc Natl Acad Sci U S A; 2014 Jan; 111(1):E89-98. PubMed ID: 24367099 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]